Manufacturer record

Vats Biotech Pvt. Ltd: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

5 batches manufactured by Vats Biotech Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between September 2022 and February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: VCT/459, Cefuroxime Axetil Tablets IP (exp May 2026). DTL Thiruvananthapuram (state lab) found it not of standard quality: Sample fails the tests Assay and Dissolution as per IP as specified in the Laboratory Protocol. Listed in the February 2026 alert.

Records by type

5 records linked to Vats Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
5Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2022 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

5
NSQ batches since 2022
5
Products affected
Assay
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2022 · 12025 · 22026 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Cefuroxime Axetil Tablets IP Batch VCT/459Mfg Jun 2024 · Exp May 2026 Sample fails the tests Assay and Dissolution as per IP as specified in the Laboratory Protocol.Assay DTL ThiruvananthapuramState lab Feb 2026
Aceclofenac, Paracetamol & Chlorzoxazone Tablets Batch VGT/2201Mfg Apr 2024 · Exp Mar 2026 Description and Assay for AceclofenacAssay RDTL, Bellary, KarnatakaState lab Jan 2026
Esyfol-XT (Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets) Batch VGT/2088Mfg Mar 2024 · Exp Feb 2026 Description and Identification & Assay for Vitamin D3Assay KarnatakaState lab Jul 2025
Cefpodoxim e Proxetil Tablets IP 200 MG (RIZDOX- 200) Batch VCT/129Mfg Aug 2023 · Exp Jul 2025 On the received sample Discoloration,rough surface and picking defects were observed which should not be present As per DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No.(i) Presence of Spot/discoloration (iv)Picking and (vii)Rough surface. - NSQDescription State Lab PuducherryState lab Jan 2025
MONTERUS-L (Montelukast Sodium & Levocetirizine Hydrochloride Tablets I.P.) Batch VBGT-094Mfg Nov 2021 · Exp Oct 2023 Dissolution and DescriptionDissolution RDTL GuwahatiState lab Sep 2022

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.